Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications

Allergy and Asthma Proceedings

Volumn 30, Issue 2, 2009, Pages 139-147

  Hauber, A Brett ^a   Mohamed, Ateesha F ^a   Johnson, F Reed ^a   Meddis, David ^b   Wagner, Samuel ^b   O'Dowd, Liza ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; Combination therapy; Conjoint analysis; Discrete choice experiment; Inhaled corticosteroid; Long acting beta adrenergic agonist; Maintenance medication; Onset of effect; Patient preferences; Survey

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; LONG ACTING DRUG; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG COST; DRUG EFFICACY; DRUG PREFERENCE; FEMALE; HEALTH SURVEY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; AGED; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; EVALUATION; FOLLOW UP; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; DRUG THERAPY, COMBINATION; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUESTIONNAIRES; RECEPTORS, ADRENERGIC, BETA-2; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650495773     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3205     Document Type: Article

References (36)

1. Akinbami L. Asthma prevalence, health care use and mortality: United States, 2003-05. Available online at www.cdc.gov/nchs/products/pubs/pubd/ hestats/ashtma03-05/asthma03-05.htm; last accessed February 5, 2008.
2. Bousquet J, Gaugris S, Sazonov Kocevar V, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the improving asthma control trial. Clin Exp Allergy 35:723-727, 2005.
3. Evans R, Mullaly D, Wilson R, et al. National trends in the morbidity and mortality of asthma in the US: Prevalence, hospitalization, and death from asthma over two decades: 1965-1984. Chest 91(suppl 6):S65-S74, 1987.
4. Lipsett M, Hurley S, and Ostro B. Air pollution and emergency room visits for asthma in Santa Clara County, California. Environ Health Perspect 105:216-222, 1997.
5. Schwartz J, Slater D, Larson T, et al. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 147:826-831, 1993.
6. Popa V. Emergency department visits in asthma: Should all be prevented? Chest 120:1058-1061, 2001.
7. Asthma and Allergy Foundation of America. The costs of asthma. Available online at www.aafa.org/display.cfm?id=8&sub=42; last accessed February 5, 2008.
8. Peters SP, Prenner BM, Mezzanotte WS, et al. Long-term safety and asthma control with budesonide/formoterol versus budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc 29:499-516, 2008.
9. Mansfield LE. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma. Allergy Asthma Proc 29:103-108, 2008.
10. Leidy NK, Patrick DL, Boggs R, et al. Perceived onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously receiving inhaled corticosteroids. J Allergy Clin Immunol 119(suppl 1):S246-S247, 2007 (Abs 965).
11. Mathias S, Parasuraman B, Petrillo J, and Leidy NK. Understanding patient perception of therapy: Development of a weekly diary to determine whether patients with asthma can feel their maintenance inhaler working right away. Value Health 10:A115, 2007 (Abs PAA23).
12. Leidy N, Patrick D, Parasuraman B, et al. Can patients with asthma feel their maintenance inhaler working right away? Reproducibility and validity of a weekly diary for assessing perception and satisfaction. Value Health 10:A115, 2007 (Abs PAA22).
13. Bateman I, Carson R, Day B, et al. Validity and reliability. In Economic Valuation with Stated Preference Techniques. Cheltenham: Edward Elgar, 296-342, 2002.
14. Bennett J, and Adamowicz V. Some fundamentals of environmental choice modeling. in The Choice Modeling Approach to Environmental Valuation, Bennett J, and Blamey R (Ed). Cheltenham: Edward Elgar, 37-69, 2001.
15. Cattin P, and Wittink D. Commercial use of conjoint analysis: A survey. J Mark 46:44-53, 1982.
16. Holmes T, and Adamowicz V. Attribute-based methods. In A Primer on Nonmarket Valuation. Champ P, Boyle K, and Brown T (Ed). Norwell: Kluwer Academic Publishers, 171-219, 2003.
17. Louviere J. Conjoint analysis modeling of stated preferences: A review of theory, methods, recent developments and external validity. J Trans Econ Policy 10:93-119, 1988.
18. Louviere J, Swait J, and Hensher D. Introduction to stated preference models and methods. In Stated Choice Methods: Analysis and Application. Cambridge, U.K.: Cambridge University Press, 20-33, 2000.
19. Ryan M, and Gerard K. Discrete choice experiments. In Assessing Quality of Life in Clinical Trials: Methods and Practice, 2nd ed. Fayers P, and R Hays (Eds). Oxford, U.K.: Oxford University Press, 431-445, 2005.
20. Huber J, and Zwerina K. The importance of utility balance in efficient choice designs. J Mark Res 33:307-317, 1996.
21. Kanninen B. Optimal design for multinomial choice experiments. J Mark Res 39:214-227, 2002.
22. Zwerina K, Huber J, and Kuhfeld W. A General Method for Constructing Efficient Choice Designs. Working paper. Durham: Fuqua School of Business, Duke University, 1996. Available online at citeseerx.ist.psu.edu/viewdoc/download? doi=10.1.1.31.9438&rep=rep1&type=pdf; last accessed Mar. 2009.
23. Dey A. Orthogonal Fractional Factorial Designs. New York: Halstead Press, 00-00, 1985.
24. Kuhfeld W, Tobias F, and Garratt M. Efficient experimental design with marketing research applications. J Mark Res 31:545-557, 1994.
25. Couper MP. Web surveys: A review of issues and approaches. Public Opin Q 64:464-494, 2000.
26. Dennis JM, and Krotki K. Probability-based survey research on the Internet. Paper presented at the 2001 Conference of the International Statistical Institute, Seoul, South Korea. August 2001.
27. Train K. Mixed logit. In Discrete Choice Methods with Simulation. Cambridge, U.K.: Cambridge University Press, 139-154, 2003.
28. Train K, and Sonnier G. Mixed logit with bounded distributions of correlated partworths. In Applications of Simulation Methods in Environmental and Resource Economics. Scarpa R, and Alberini A (Eds). Dordrecht: Springer Publisher, 117-134, 2005.
29. Osman LM, McKenzie L, Cairns J, et al. Patient weighting of importance of asthma symptoms. Thorax 56:138-142, 2001.
30. Johansson G, Ställberg B, Tornling G, et al. Asthma treatment preference study: A conjoint analysis of preferred drug treatments. Chest 125:916-923, 2004.
31. Bender BG, Long A, Parasuraman B, and Tran ZV. Factors influencing patient decisions about the use of asthma controller medication. Ann Allergy Asthma Immunol 98:322-328, 2007.
32. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 3 (EPR3), 2007. Available online at www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm; last accessed March 10, 2008.
33. Sovani MP, Whale CI, Oborne J, et al. Poor adherence with inhaled corticosteroids for asthma: Can using a single inhaler containing budesonide and formoterol help? Br J Gen Pract 58:37-43, 2008.
34. Stoloff SW, Stempel DA, Meyer J, et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 113:245-251, 2004.
35. Shapiro G, Lumry W, Wolfe J, et al. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 161:527-534, 2000.
36. Centers for Disease Control, National Center for Health Statistics. Summary health statistics for U.S. adults, National Health Interview Survey, 2005. Vital Health Stat 10:19-22, 2006.